Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Origin recognition complex subunit 6 (ORC6) is the sixth and smallest subunit of the origin recognition complex (ORC), a highly conserved six-protein complex essential for the initiation of DNA replication in eukaryotic cells[2][3][4]. ORC6 is encoded by the *ORC6* gene (also called *ORC6L*) and plays a key DNA-binding role, anchoring the ORC to replication origins and facilitating pre-replication complex assembly[1][6]. Structurally, human ORC6 contains three independent domains and a distinct DNA-binding domain[4]. Functionally, ORC6 is essential for viability and proper chromosome replication and segregation; it also plays a role in cytokinesis, sometimes independently of the ORC[2][4][5]. In humans, mutations can result in syndromes characterized by developmental defects, including Meier-Gorlin syndrome[4]. ORC6 is not a typical therapeutic target, with no direct drugs acting upon it, but it is crucial for understanding DNA replication and cell division biology.
not a direct drug target; mechanism data associated with DNA binding and protein-protein interactions within the pre-replication complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Origin recognition complex subunit 6 (ORC6).